- Dr. Daozhi Liu from MicroPort will share the details in BioMed China 2013 in March
SHANGHAI, Jan. 22, 2013 /PRNewswire/ -- The "hot cake" of the China medical devices market has attracted close eyes from EU/US companies. With a perfect blend of local and international market intelligence, Dr. Daozhi Liu from MicroPort will share details about the future of biomedical materials in the Chinese market this March at BioMed China 2013.
Dr. Daozhi Liu is currently Senior Vice President of Emerging Business at Shanghai MicroPort Medical (Group) Limited. He obtained his bachelor's and Ph.D. in China in 1985 and 1991, as well as engaged in postdoctoral research at the University of Oxford from 1993 to 1994. He returned from overseas to join MicroPort Medical (Shanghai) Co., Ltd. as one of the core members of the early entrepreneurial team, former research center director, vice president, senior vice president, business general manager, Ortho business company legal representative and executive director. From 2003 until now, he established MicroPort's emerging business of cardiac electrophysiological medical equipment: pacemakers and orthopedic medical devices. He is also the founder and GM of Shanghai MicroPort Orthopedics Co., Ltd., a sub-branch of MicroPort in Shanghai.
Apart from presenting at BioMed China 2013 on March 14 in Shanghai, Dr. Daozhi Liu will also serve as the chairman for the full day conference and panel discussions, as well as share both his local and global key insights on biomedical materials, investment opportunities, and product value evaluation.
For more details about BioMed China 2013 and Dr. Liu's speech, please visit the event website at http://www.biomed-innovation.com/en/Index.asp. Free PowerPoint Presentations from past events can be downloaded at http://www.biomed-innovation.com/en/feedbacka.asp?Id=97.
BioMed is hosted by UBM Conferences.
